Harmony Biosciences Holdings Inc. (HRMY) Company Bio
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Harmony Biosciences (HRMY) has gone public in an offering which has been a big success with shares up 60% on their opening day of trading (halfway the session) after pricing was already set above the preliminary offering range. Right here and now, the pharmaceutical company, with one approved product, trades...
The Value Investor on Seeking Alpha | August 20, 2020